NIAID Site Search

NIAID requires your human subjects research plans to include women, minorities, and participants of all ages unless you can justify their exclusion.

Last Reviewed: January 24, 2022

This document provides an overview of Simulator GUI software including an explanation of various features and how to use them.

Last Reviewed: January 1, 2012

This WORD document provides a tool for evaluating organization review, coordinate and maintain oversight of all applications and proposal

Last Reviewed: August 6, 2019

This document outlines the guidelines for the diagnosis and management of food allergy in the US, specifically for patients, families, and caregivers.

Last Reviewed: July 9, 2019

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Last Reviewed: March 28, 2024

Sample grant summary statement from DeAnna Friedman-Klabanoff, M.D for NIH Mentored Patient-Oriented Research Career Development Award (K23)

Last Reviewed: April 19, 2024

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

Sample application from Nicole Putnam, Ph.D., for National Research Service Award (NRSA) individual fellowship (F31) grants.

Last Reviewed: January 25, 2023

This PDF provides a tool for evaluating organization review, coordinate and maintain oversight of all applications and proposal

Last Reviewed: November 26, 2019

NIAID Pharmacy guidelines and instructions for Division of Allergy, Immunology, and Transplantation (DAIT) clinical trials and networks

Last Reviewed: July 9, 2019

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: October 10, 2023

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: October 6, 2022

Memo from NIAID Division of AIDS (DAIDS): Revised Common Rule regulation and the application of this rule starting in 2019.

Last Reviewed: June 10, 2020

On this page, we give you detailed information about writing an effective Research Plan when applying for a NIH grant.

Last Reviewed: January 8, 2025

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024

Information for researchers about which changes can be made to grants independently and which require NIAID permission.

Last Reviewed: September 29, 2023